Detalles de la búsqueda
1.
Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study.
Front Cardiovasc Med
; 9: 821322, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-37168321
Resultados
1 -
1
de 1
1
Próxima >
>>